Log in

Relevant bibliographies by topics / Respiratory diseases – Treatment / Journal articles

To see the other types of publications on this topic, follow the link: Respiratory diseases – Treatment.

Journal articles on the topic 'Respiratory diseases – Treatment'

Author: Grafiati

Published: 4 June 2021

Last updated: 8 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Respiratory diseases – Treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

CHERVINSKAYA, ALINA V., and NORA A. ZILBER. "Halotherapy for Treatment of Respiratory Diseases." Journal of Aerosol Medicine 8, no. 3 (1995): 221–32. http://dx.doi.org/10.1089/jam.1995.8.221.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

ITOH, Takashi. "Kampo Treatment for Respiratory Tract Diseases." Kampo Medicine 54, no. 1 (2003): 29–46. http://dx.doi.org/10.3937/kampomed.54.29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Starostina, L. S. "Treatment of respiratory diseases with inhalation patches." Medical Council, no. 11 (July 18, 2019): 89–94. http://dx.doi.org/10.21518/2079-701x-2019-11-89-94.

Full text

Abstract:

The high incidence of respiratory infections at an early age requires constant attention of doctors of various specialties. It should be born in mind that the development of the respiratory tract in young children has unique features, and that different drugs can have different effects on the mucous membrane and ciliated epithelium. Also take into account the possibility of using different ways drugs can be administered to prevent and treat respiratory infections with due account for the age of the child, the effectiveness of action and adverse events risk reduction.

APA, Harvard, Vancouver, ISO, and other styles

4

Colquhoun, Michael. "Drugs for the treatment of respiratory diseases." Resuscitation 59, no. 1 (2003): 155. http://dx.doi.org/10.1016/s0300-9572(03)00165-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Nagalingam, Nabeetha A., Emily K. Cope, and Susan V. Lynch. "Probiotic strategies for treatment of respiratory diseases." Trends in Microbiology 21, no. 9 (2013): 485–92. http://dx.doi.org/10.1016/j.tim.2013.04.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Blyde, David J. "Respiratory Diseases, Diagnostics, and Treatment of Marsupials." Veterinary Clinics of North America: Exotic Animal Practice 3, no. 2 (2000): 497–512. http://dx.doi.org/10.1016/s1094-9194(17)30084-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Baiardini, Ilaria, Silviya Novakova, Stefan Mihaicuta, Ipek Kivilcim Oguzulgen, and Giorgio Walter Canonica. "Adherence to treatment in allergic respiratory diseases." Expert Review of Respiratory Medicine 13, no. 1 (2018): 53–62. http://dx.doi.org/10.1080/17476348.2019.1554438.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sharad K., Kamble, and Shinde Sunita S. "Coronavirus Diseases: Prevention and Treatment." Sumerianz Journal of Medical and Healthcare, no. 312 (December 28, 2020): 117–19. http://dx.doi.org/10.47752/sjmh.312.117.119.

Full text

Abstract:

The first coronavirus (infectious bronchitis virus) was quarantined in chicken embryos in 1937 with subsequent viral isolations in rodents, domestic animals, and humans. Coronaviruses are a family of viruses that can cause infections such as the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). The seven coronaviruses are 229E, NL63, OC43, HKU1, MERS-CoV, SARS-CoV, SARS-CoV-2 that can infect people. There is currently no vaccine to prevent coronavirus disease also there no antiviral medication is suggested to treat COVID-19. The best way to inhibit infection

APA, Harvard, Vancouver, ISO, and other styles

9

Simonova, A. Yu. "CLARYTROMYCIN IN TREATMENT OF PEDIATRIC ACUTE RESPIRATORY DISEASES." Current pediatrics 11, no. 1 (2012): 152. http://dx.doi.org/10.15690/vsp.v11i1.148.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Guerra, A., N. E. Campillo, and J. A. Páez. "Glycopyrrolate combinations for the treatment of respiratory diseases." Expert Opinion on Therapeutic Patents 16, no. 5 (2006): 723–28. http://dx.doi.org/10.1517/13543776.16.5.723.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Burkin, A. V., V. M. Svistushkin, G. N. Nikiforova, and A. S. Dukhanin. "Glucosaminylmuramyl dipeptide in treatment of respiratory tract diseases." Vestnik otorinolaringologii 84, no. 6 (2019): 118. http://dx.doi.org/10.17116/otorino201984061118.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Blokhin, B. M., and I. P. Lobushkova. "Cough Treatment in Acute Respiratory Diseases in Children." Doctor.Ru 160, no. 5 (2019): 15–18. http://dx.doi.org/10.31550/1727-2378-2019-160-5-15-18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Mascitelli, L., and F. Pezzetta. "Treatment of chronic respiratory diseases in obese people." Canadian Medical Association Journal 176, no. 8 (2007): 1130. http://dx.doi.org/10.1503/cmaj.1060122.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Orlova, N. V. "Complex therapy of acute respiratory diseases." Medical Council, no. 15 (December 8, 2019): 91–97. http://dx.doi.org/10.21518/2079-701x-2019-15-91-97.

Full text

Abstract:

Acute respiratory disease (ARD) is a common pathology. Untimely diagnosis and treatment, co-morbidities, old age and children under 1 year of age, pregnancy can increase the severity of the condition and lead to complications and death. According to IDSA recommendations, vaccination is an effective way to prevent complications and fatal influenza cases. Vaccination is primarily for people at risk of serious illness. In cases of suspected influenza, molecular diagnostics is recommended. At the same time, treatment of suspected influenza should be prescribed immediately, without waiting for labo

APA, Harvard, Vancouver, ISO, and other styles

15

Teper, Alejandro, Gilberto B. Fischer, and Marcus Herbert Jones. "Respiratory sequelae of viral diseases: from diagnosis to treatment." Jornal de Pediatria 78, no. 8 (2002): 187–94. http://dx.doi.org/10.2223/jped.897.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Tatsumi, Koichiro. "Kampo Medicine in the Treatment of Respiratory Airway Diseases." Nihon Kikan Shokudoka Gakkai Kaiho 60, no. 5 (2009): 393–400. http://dx.doi.org/10.2468/jbes.60.393.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Suzuki, Junzo, and Katsutoshi Nagasawa. "Kampo Medicine for Treatment of Respiratory Diseases in Children." Nihon Kikan Shokudoka Gakkai Kaiho 60, no. 5 (2009): 409–16. http://dx.doi.org/10.2468/jbes.60.409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Chung, Jin Hong. "Advances in the science and treatment of respiratory diseases." Yeungnam University Journal of Medicine 37, no. 4 (2020): 251–52. http://dx.doi.org/10.12701/yujm.2020.00661.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Yarullina, E. S. "COMPREHENSIVE APPROACH TO TREATMENT OF RESPIRATORY DISEASES OF CALVES." Scientific Notes Kazan Bauman State Academy of Veterinary Medicine 242, no. 2 (2020): 222–26. http://dx.doi.org/10.31588/2413-4201-1883-242-2-222-226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Pleasants, Roy A. "Book Review: Drugs for the Treatment of Respiratory Diseases." Annals of Pharmacotherapy 38, no. 4 (2004): 724. http://dx.doi.org/10.1345/aph.1d435.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Zhong, Nan-Shan, and Guang-Qiao Zeng. "Prevention and treatment of chronic respiratory diseases in China." Chronic Diseases and Translational Medicine 5, no. 4 (2019): 209–13. http://dx.doi.org/10.1016/j.cdtm.2019.12.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Crosta, Lorenzo. "Respiratory Diseases of Parrots: Anatomy, Physiology, Diagnosis and Treatment." Veterinary Clinics of North America: Exotic Animal Practice 24, no. 2 (2021): 397–418. http://dx.doi.org/10.1016/j.cvex.2021.01.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Pelletier, Lawrence L. "TREATMENT OF RESPIRATORY TRACT INFECTIONS." Infectious Diseases in Clinical Practice 7, Supplement 5 (1998): S316—S323. http://dx.doi.org/10.1097/00019048-199812005-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Kang, Sung-Yoon, Min-Suk Yang, Sang Min Lee, and Sang Pyo Lee. "Allergen-Specific Immunotherapy Against Allergic Respiratory Diseases." Korean Journal of Medicine 95, no. 6 (2020): 370–76. http://dx.doi.org/10.3904/kjm.2020.95.6.370.

Full text

Abstract:

Allergen-specific immunotherapy (AIT) can alter the natural course of an allergic disease. It is widely held that the efficacy of a given therapeutic modality should be proven by well-designed double-blind placebo-controlled randomized clinical trials and meta-analyses. In this article, the therapeutic efficacy of AIT for allergic respiratory diseases, such as allergic rhinitis and asthma, is reviewed. In addition, potential clinical and experimental predictors of the treatment response are reviewed for AITs requiring long-term treatment, and for some allergic rhinitis and asthma patients who

APA, Harvard, Vancouver, ISO, and other styles

25

Macfadden, D. K., J. D. Edelson, and A. S. Rebuck. "Treatment of Respiratory Failure in AIDS." Clinical Infectious Diseases 10, no. 1 (1988): 230–31. http://dx.doi.org/10.1093/clinids/10.1.230.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Rapoport, S. I., and Nona A. Shubina. "Respiratory tests in diagnostics of renal diseases." Clinical Medicine (Russian Journal) 94, no. 12 (2017): 885–92. http://dx.doi.org/10.18821/0023-2149-2016-94-12-885-892.

Full text

Abstract:

C breath tests are the highly efficient noninvasive tools for estimation of liver condition. They provide a basis for the solution of many problems encountered in diagnostics and treatment of hepatic deseases including surgery, chemotherapy and transplantation.

APA, Harvard, Vancouver, ISO, and other styles

27

Giménez, GC, F. Prado, MV Herrero, and JR Bach. "Treatment alternatives in patients with neuromuscular pathologies and respiratory diseases." Anales de la Facultad de Ciencias Médicas (Asunción) 50, no. 2 (2017): 79–88. http://dx.doi.org/10.18004/anales/2017.050(02)79-088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Melnychuk, L. V., O. H. Dolzhenko, and I. B. Rehulska. "PROBLEM ISSUES OF THE TREATMENT OF RESPIRATORY DISEASES IN CHILDREN." Bukovinian Medical Herald 21, no. 2 (82) p.1 (2017): 27–30. http://dx.doi.org/10.24061/2413-0737.xxi.2.82.1.2017.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Trapani, Adriana, Sante Gioia, Stefano Castellani, et al. "Nanocarriers for Respiratory Diseases Treatment: Recent Advances and Current Challenges." Current Topics in Medicinal Chemistry 14, no. 9 (2014): 1133–47. http://dx.doi.org/10.2174/1568026614666140329225817.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Kotov, R. V., and I. V. Rakhmanova. "MODERN CONCEPTION OF PEDIATRIC ACUTE UPPER RESPIRATORY TRACT DISEASES TREATMENT." Current pediatrics 11, no. 1 (2012): 107. http://dx.doi.org/10.15690/vsp.v11i1.140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Duda, O. K., V. O. Boyko, L. P. Kotsiubailo, and A. I. Konoplianik. "Ambroxol in comprehensive treatment of patients with acute respiratory diseases." Health of Society 6, no. 3 (2017): 55–58. http://dx.doi.org/10.22141/2306-2436.6.3.2017.123493.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Marushko, Iu, Т. Gischak, О. Lysovetz, M. Muka, and E. Marushko. "Antitussive and expectorant treatment with acute respiratory diseases in children." SOVREMENNAYA PEDIATRIYA, no. 6(70) (November 15, 2015): 51–55. http://dx.doi.org/10.15574/sp.2015.70.51.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Pellegrino, M., E. Albamonte, M. F. Lanata, et al. "P136 Treatment of nutritional and respiratory disturbs in neuromuscular diseases." Digestive and Liver Disease 50, no. 4 (2018): e405. http://dx.doi.org/10.1016/s1590-8658(18)31134-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Dal Negro, Roberto, Edoardo Pozzi, and Silvano G. Cella. "Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases." Pulmonary Pharmacology & Therapeutics 53 (December 2018): 80–85. http://dx.doi.org/10.1016/j.pupt.2018.10.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Ryabova, M. A., O. V. Lavrova, N. A. Shumilova, and L. V. Georgieva. "Treatment of the upper respiratory tract diseases in pregnant women." Practical medicine 16, no. 5 (2018): 81–84. http://dx.doi.org/10.32000/2072-1757-2018-16-5-81-84.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Kudlacz, Elizabeth M. "Combined tachykinin receptor antagonists for the treatment of respiratory diseases." Expert Opinion on Investigational Drugs 7, no. 7 (1998): 1055–62. http://dx.doi.org/10.1517/13543784.7.7.1055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Vladeva, Evgeniya. "Halotherapy – an alternative method for the treatment of respiratory diseases." Heart - Lung (Varna) 21, no. 1-2 (2015): 31. http://dx.doi.org/10.14748/hl.v21i1-2.5050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Lissoni, A., and F. Molteni. "Pathogenesis of respiratory failure in neuromuscular diseases: Diagnosis and treatment." Italian Journal of Neurological Sciences 7, no. 5 (1986): 499–504. http://dx.doi.org/10.1007/bf02342028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Chang, Lydia H., and M. Patricia Rivera. "Respiratory Diseases: Meeting the Challenges of Screening, Prevention, and Treatment." North Carolina Medical Journal 74, no. 5 (2013): 385–92. http://dx.doi.org/10.18043/ncm.74.5.385.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

GRONEBERG, D., S. POUTANEN, D. LOW, H. LODE, T. WELTE, and P. ZABEL. "Treatment and vaccines for severe acute respiratory syndrome." Lancet Infectious Diseases 5, no. 3 (2005): 147–55. http://dx.doi.org/10.1016/s1473-3099(05)70022-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Sinkov, Eduard V. "Upper respiratory tract diseases in patients with cystic fibrosis." Consilium Medicum 23, no. 9 (2021): 441–44. http://dx.doi.org/10.26442/20751753.2021.9.201024.

Full text

Abstract:

Among ENT organ diseases in patients with cystic fibrosis, chronic rhinosinusitis is leading. The respiratory epithelium lining the surface of the upper and lower respiratory tract has the same structure. And as a result, in patients with cystic fibrosis, along with the bronchial tree, the upper respiratory tract is involved in the inflammatory process, while chronic rhinosinusitis develops. Impaired drainage leads to stagnation of infected thick mucus. Timely examination and treatment of upper respiratory pathology in patients with cystic fibrosis is needed. In surgical treatment, the method

APA, Harvard, Vancouver, ISO, and other styles

42

Dolen, William K. "Allergic Diseases: Diagnosis and Treatment." Annals of Allergy, Asthma & Immunology 80, no. 1 (1998): 77. http://dx.doi.org/10.1016/s1081-1206(10)62944-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Askandar, Rafee H., and Nasim Ebrahimi. "The Impact of Probiotics in Respiratory Diseases." Polytechnic Journal 10, no. 1 (2020): 148–56. http://dx.doi.org/10.25156/ptj.v10n1y2020.pp148-156.

Full text

Abstract:

Probiotics are viable microorganisms that, if adequately administered, confer great benefits to the host for the prevention or treatment of a wide range of human diseases, including recurrent respiratory tract infection (RRTI), cystic fibrosis, allergies, and chronic obstructive pulmonary disease (COPD). One of the current problems is that the overuse of antibiotics during respiratory tract infection has led to increased resistance to them, which has been demonstrated in numerous examinations that specific lactic acid bacteria (LAB), one of the key probiotics, against bacterial and viral infec

APA, Harvard, Vancouver, ISO, and other styles

44

Morozova, S. V. Morozova, and L. A. Keda Keda. "Prevention and treatment of upper respiratory tract diseases complicating the course of acute respiratory infections." Pharmateca 5_2020 (June 5, 2020): 46–50. http://dx.doi.org/10.18565/pharmateca.2020.5.46-50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Jung, Ki Suck, and O. Jung Kwon. "Treatment of Acute Respiratory Distress Syndrome." Tuberculosis and Respiratory Diseases 51, no. 1 (2001): 5. http://dx.doi.org/10.4046/trd.2001.51.1.5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Lai, S. T. "Treatment of severe acute respiratory syndrome." European Journal of Clinical Microbiology & Infectious Diseases 24, no. 9 (2005): 583–91. http://dx.doi.org/10.1007/s10096-005-0004-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Drozdov, V. N., S. Yu Serebrova, O. А. Vorobyeva, A. K. Starodubtsev, and O. V. Dobrovolsky. "Current opportunities for the treatment of respiratory diseases in paediatric practice." Medical Council, no. 17 (October 22, 2018): 132–36. http://dx.doi.org/10.21518/2079-701x-2018-17-132-136.

Full text

Abstract:

Immediacy of the problem of combination therapy of respiratory diseases in paediatric practice is caused by their multifactorial pathogenesis in children and the need to achieve a high clinical effect in the use of drugs at relatively low doses and with minimum risks of serious adverse effects and drug interactions. The fixed-dose combination of salbutamol, bromhexine and guaifenesin produced in the form of tablets and syrup fully meets these requirements, which makes it possible to use it in children and adults with acute, chronic infectious (ARVI, bacterial pneumonia, respiratory tuberculosi

APA, Harvard, Vancouver, ISO, and other styles

48

Tzouvelekis, Argyris, Paschalis Ntolios, and Demosthenes Bouros. "Stem Cell Treatment for Chronic Lung Diseases." Respiration 85, no. 3 (2013): 179–92. http://dx.doi.org/10.1159/000346525.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Barbosa, Anne Karynne da Silva, and Wenna Lúcia Lima. "Correlation between ginseng radix and the novel coronavirus about a possible future alternative treatment." Research, Society and Development 9, no. 8 (2020): e712985720. http://dx.doi.org/10.33448/rsd-v9i8.5720.

Full text

Abstract:

In 2019 in Wuhan city (China), is was outbreak about a novel coronavirus, causes an infections respirator, in children and adults, and is new condition was call for COVID-19. The present study being about herbal medicines and their correlation with diseases on respiratory tract basically COVID-19. To date, there are no studies showing how Ginseng Radix cooperated with the prevention or for to treat coronavirus diseases, so the aimed the present study was a to analyze in literature about this. The aim is to observe the correlation about the Ginseng Radix as a future treatment in novel coronavir

APA, Harvard, Vancouver, ISO, and other styles

50

Ferrari, Nicolay, Rosanne Seguin, and Paolo Renzi. "Oligonucleotides: a multi-targeted approach for the treatment of respiratory diseases." Future Medicinal Chemistry 3, no. 13 (2011): 1647–62. http://dx.doi.org/10.4155/fmc.11.108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!